ENERGI-F703 gel, as a new topical treatment for diabetic foot and leg ulcers: A multicenter, randomized, double-blind, phase II trial

BACKGROUND: Diabetic foot and leg ulcers are a major cause of disability among patients with diabetes mellitus. A topical gel called ENERGI-F703, applied twice daily and with adenine as its active pharmaceutical ingredient, accelerated wound healing in diabetic mice. The current study evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jui-Yung, Chen, Cha-Chun, Chang, Shun-Cheng, Yeh, Jiun-Ting, Huang, Hui-Fu, Lin, Hwang-Chi, Lin, Shang-Hsi, Lin, Yu-Hsien, Wei, Lin-Gwei, Liu, Tom J., Hung, Shih-Yuan, Yang, Hui-Mei, Chang, Hui-Hsiu, Wang, Chih-Hsin, Tzeng, Yuan-Sheng, Huang, Chieh-Huei, Chou, Chang-Yi, Lin, Ying-Sheng, Yang, Shih-Yi, Chen, Han-Min, Lin, Jiun-Tsai, Cheng, Yi-Fang, Young, Guang-Huar, Huang, Chun-Fang, Kuo, Ya-Chun, Dai, Niann-Tzyy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284381/
https://www.ncbi.nlm.nih.gov/pubmed/35844773
http://dx.doi.org/10.1016/j.eclinm.2022.101497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284381/
https://www.ncbi.nlm.nih.gov/pubmed/35844773
http://dx.doi.org/10.1016/j.eclinm.2022.101497

Ejemplares similares